PMGC Holdings ELAB
NASDAQ ELAB
$6.66 +0.56 (+9.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Change in Acquisitions & Divestments (2025 - 2026)

PMGC Holdings (ELAB) posted Change in Acquisitions & Divestments of $1.3 million for Q1 2026, up 158.69% sequentially from $515973.0 in Q4 2025, and up 521.68% YoY from $214705.0 in Q1 2025.

PMGC Holdings (ELAB) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

PMGC Holdings has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $1.3 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 521.68% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (changed N/A YoY) and the FY2025 annual result came in at $1.8 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments rose to $1.3 million in Q1 2026 per ELAB's latest filing, from $515973.0 in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $1.3 million in Q1 2026 and troughed at $136307.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 PMGC Holdings 31.22 Mn 12.43 Mn 385,691.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1.33 Mn
Mar 31, 2026 1.33 Mn
Dec 31, 2025 515,973.00
Dec 31, 2025 515,973.00
Sep 30, 2025 136,307.00
Sep 30, 2025 136,307.00
Jun 30, 2025 895,216.00
Jun 30, 2025 895,216.00
Mar 31, 2025 214,705.00
Mar 31, 2025 214,705.00